基于三路径三维卷积神经网络的脑转移瘤放射外科剂量处方临床决策人工智能建模
纳入2017至2021年接受放射外科治疗的152例脑转移瘤患者,提取8项临床参数和CT及靶区、危及器官轮廓,构建三路径三维卷积神经网络模拟剂量处方决策。模型在19折交叉验证中正确预测124例(82%)的处方,纳入临床参数使总体预测准确率提高20%。
要点
- 152例脑转移瘤放射外科病例中,模型正确预测124例(82%)的剂量处方。
- 各处方类型正确率:1×24 Gy为44/48例(92%),1×20-22 Gy为36/48例(75%)。
- 纳入临床参数使模型总体预测准确率提高20%。
核心结论
- 据作者所知,这是首个证明人工智能预测放射治疗临床决策中剂量处方可行性的研究。
- 此类临床决策模型可通过为欠发达地区患者提供初步咨询来帮助解决医疗资源不均,或作为医生交叉核对机构内外实践的质量保证工具。
研究设计与样本
- 纳入2017至2021年接受放射外科治疗的152例脑转移瘤患者,导出CT图像及肿瘤和危及器官轮廓。
- 提取并数字化8项相关临床参数:年龄、病灶数量、体能状态(ECOG)、有无症状、与手术的安排(术前或术后放疗)、再治疗、原发癌类型及转移至其他部位。
- 构建三路径三维卷积神经网络,三路径使用相同卷积核和滤波器,分别捕捉肿瘤特征(大小和位置)、肿瘤与危及器官的相对空间关系及临床参数。
- 模型融合三路径信息预测剂量处方,以患者记录中的实际处方作为模型训练的金标准。
- 采用19折交叉验证评估模型性能,每折随机选取128例训练、16例验证和8例测试受试者。
主要发现
- 152例患者的剂量处方包括48例1×24 Gy、48例1×20-22 Gy、32例3×9 Gy和24例5×6 Gy,由8位医生开具。
- 模型正确预测124例(82%)的处方,其中1×24 Gy正确44例(92%)、1×20-22 Gy正确36例(75%)、3×9 Gy正确25例(78%)、5×6 Gy正确19例(79%)。
- 对失败病例的分析显示,潜在原因是各医生之间的实践差异,而基于组数据训练的模型未考虑这些差异。
- 纳入临床参数使总体预测准确率提高20%。
局限性
- 对失败病例的分析显示,潜在原因是各医生之间的实践差异,而基于组数据训练的模型未考虑这些差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: AI modeling physicians' clinical decision-making (CDM) can improve the efficiency and accuracy of clinical practice or serve as a surrogate to provide initial consultations to patients seeking secondary opinions. In this study, we developed an AI network to model radiotherapy CDM and used dose prescription as an example to demonstrate its feasibility. MATERIALS/METHODS: 152 patients with brain metastases treated by radiosurgery from 2017 to 2021 were included. CT images and tumor and organ-at-risk (OAR) contours were exported. Eight relevant clinical parameters were extracted and digitized, including age, numbers of lesions, performance status (ECOG), presence of symptoms, arrangement with surgery (pre- or post-surgery radiation therapy), re-treatment, primary cancer type, and metastasis to other sites. A 3D convolutional neural network (CNN) architecture was built using three encoding paths with the same kernel and filters to capture the different image and contour features. Specifically, one path was built to capture the tumor feature, including the size and location of the tumor, another path was built to capture the relative spatial relationship between the tumor and OARs, and the third path was built to capture the clinical parameters. The model combines information from three paths to predict dose prescription. The actual prescription in the patient record was used as ground truth for model training. The model performance was assessed by 19-fold-cross-validation, with each fold consisting of randomly selected 128 training, 16 validation, and 8 testing subjects. RESULT: The dose prescriptions of 152 patient cases included 48 cases with 1 × 24 Gy, 48 cases with 1 × 20-22 Gy, 32 cases with 3 × 9 Gy, and 24 cases with 5 × 6 Gy prescribed by 8 physicians. The AI model prescribed correctly for 124 (82 %) cases, including 44 (92 %) cases with 1 × 24 Gy, 36 (75 %) cases with 1 × 20-22 Gy, 25 (78 %) cases with 3 × 9 Gy, and 19 (79 %) cases with 5 × 6 Gy. Analysis of the failed cases showed the potential cause of practice variations across individual physicians, which were not accounted for in the model trained by the group data. Including clinical parameters improved the overall prediction accuracy by 20 %. CONCLUSION: To our best knowledge, this is the first study to demonstrate the feasibility of AI in predicting dose prescription in CDM in radiation therapy. Such CDM models can serve as vital tools to address healthcare disparities by providing preliminary consultations to patients in underdeveloped areas or as a valuable quality assurance (QA) tool for physicians to cross-check intra- and inter-institution practices.
引用
- Cao Y, Kunaprayoon D, Xu J, et al. AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN. Clin Transl Radiat Oncol. 2022. PMID: 36594076. doi:10.1016/j.ctro.2022.100565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。